HCA shares fall -9.3% premarket in hospital operators sector after results and guidance; Q2 revs $20.23B vs. est. $19.43B but narrowed its F
HCA shares fall -9.3% premarket in hospital operators sector after results and guidance; Q2 revs $20.23B vs. est. $19.43B but narrowed its Fy26 rev outlook to $77B-$79.5B from prior $76.5B-$80B view and also lowered its 2026 net Income outlook to $6.3B-$6.7B from prior $6.495B-$7.035B and lower EPS view of $28.70-$30.50, down from $29.10-$31.50 prior; said a service mix shift, mainly from a decline in Surgical volume, negatively affected results (watch shares of THC, UHS, CYH in hospitals).
HCA shares fall -9.3% premarket in hospital operators sector after results and guidance; Q2 revs $20.23B vs. est. $19.43B but narrowed its Fy26 rev outlook to $77B-$79.5B from prior $76.5B-$80B view and also lowered its 2026 net Income outlook to $6.3B-$6.7B from prior $6.495B-$7.035B and lower EPS view of $28.70-$30.50, down from $29.10-$31.50 prior; said a service mix shift, mainly from a decline in Surgical volume, negatively affected results (watch shares of THC, UHS, CYH in hospitals).